Cyrano believes that the electronic nose would provide physicians with a quicker and more accurate diagnostic tool. Applications could include obtaining objective information on the identity of certain chemical compounds in exhaled air and excreted urine or body fluids related to specific metabolic conditions, certain skin diseases or bacterial infections, such as those common to leg or burn wounds. Additionally, the electronic nose may provide more accurate, real-time patient monitoring during anesthesia administration.
Cyrano is sponsoring medical research at two institutions to evaluate the effectiveness of this technology in medical applications. In a study with the Hospital of the University of Pennsylvania the focus is on the ability of the electronic nose to detect Ventilator Associate Pneumonia and other upper respiratory bacterial infections. In a study with the Cleveland Clinic Foundation, Cyrano's technology is being evaluated in its ability to detect pulmonary diseases.